Novel findings on GRB2 and SOS1 could pave the way for cancer treatments

Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.

Roundup: Medtech M&A slump continues but analysts predict uptick in 2024

Medtech M&A was down for the second straight year after an explosion of deal-making in 2021, with deal volumes down compared to prior years and

December 19, 2023

Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug

CHICAGO — Something is off about the way Novartis is talking about pelabresib, its newly acquired and costly treatment for myelofibrosis. I suspect the Swiss

June 4, 2024

Opinion | Bring Environmental Sustainability to Your Practice in 2025

Sack is an associate clinical professor, a gastroenterologist, and executive director and editor of My Green Doctor. Healthcare practices have a significant environmental impact, and

February 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.